// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Many of those who have come to Armenia have found shelter with their relatives or friends, who basically belong to a lower class of society.
A study published today in Nature Climate Change predicts that deadly heatwaves will become more frequent in the future.
For the current study, researchers examined data from surveys of teens in 61 countries conducted from 2012 to 2015.
“The architectural part is almost ready, and only several issues remain to be tackled,” Tigran Chibukhchyan said.
Partner news